Febuxostat is used for: Gout; Hyperuricemia.
Recorded in the NepalDoc medicine catalog for Febuxostat.
Febuxostat Tablets are a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.
From the U.S. FDA-approved label for Febuxostat. Full label: DailyMed.
Febuxostat Tablets are a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.
From the U.S. FDA-approved label for Febuxostat. Full label: DailyMed.
Recommended dosage is 40 mg or 80 mg once daily. The recommended starting dosage is 40 mg once daily. For patients who do not achieve a serum uric acid (sUA) less than 6 mg/dL after 2 weeks, the recommended dosage is 80 mg once daily., Patients with severe renal impairment: Limit the dosage to 40 mg once daily., Flare prophylaxis is recommended upon initiation of Febuxostat Tablets., Can be administered without regard to food or antacid use.
Directions from the U.S. FDA-approved label for Febuxostat — your doctor or pharmacist may advise differently.
Febuxostat Tablets are contraindicated in patients being treated with azathioprine or mercaptopurine. Febuxostat Tablets are contraindicated in patients being treated with azathioprine or mercaptopurine.
Excerpt from the U.S. FDA-approved label for Febuxostat. Talk to a pharmacist or doctor before use.
Gout Flares: An increase in gout flares is frequently observed after initiation of febuxostat. If a gout flare occurs during treatment, febuxostat need not be discontinued. Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug or colchicine) upon initiation of treatment may be beneficial for up to six months., Hepatic Effects: Cases of hepatic failure, some fatal, have been reported. If liver injury is detected, promptly interrupt febuxostat and treat cause, if possible, to resolution or stabilization.
Warnings and precautions excerpt from the U.S. FDA-approved label for Febuxostat — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described elsewhere in the prescribing information: Cardiovascular Death, Hepatic Effects, Serious Skin Reactions Adverse reactions in ≥ 1% of patients treated with Febuxostat Tablets are liver function abnormalities, nausea, arthralgia, and rash. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc.
Excerpt from the U.S. FDA-approved label for Febuxostat — not a complete list. Talk to a pharmacist or doctor about side effects.
34 brands · 15 makers in the NepalDoc catalog — see the full Febuxostat guide →
Protect from light. Store at 20˚ to 25°C (68˚ to 77°F).
Storage information from the U.S. FDA-approved label for Febuxostat.
What is Febarto?
Febarto 40mg Tablet is a Febuxostat medicine made by Panacea Biotec Ltd. It comes as 40mg Tablet.
What is Febarto used for?
Febuxostat is used for Gout, Hyperuricemia.
What is the generic name of Febarto?
The generic name of Febarto is Febuxostat.
Which brands of Febuxostat are available in Nepal?
34 brands of Febuxostat are listed in the NepalDoc catalog, from 15 makers — including Appostat 40mg Tablet, Appostat 80mg Tablet, F stat 40mg Tablet, F stat 80mg Tablet, F-STAT 80mg Tablet, F-STAT 40mg Tablet.
What are the side effects of Febuxostat?
The following serious adverse reactions are described elsewhere in the prescribing information: Cardiovascular Death, Hepatic Effects, Serious Skin Reactions Adverse reactions in ≥ 1% of patients treated with Febuxostat Tablets are liver function abnormalities, nausea, arthralgia, and rash.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
